V026-5549 Screening compound: 4-fluoro-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-(2-phenylethyl)benzamide

V026-5549 Screening compound: 4-fluoro-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-(2-phenylethyl)benzamide
V026-5549 Screening compound: 4-fluoro-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-(2-phenylethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V026-5549
4-fluoro-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-(2-phenylethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V026-5549

Molecular Formula

C32H32FN5O2 (C32 H32 FN5 O2)

Compound Name

4-fluoro-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-(2-phenylethyl)benzamide

IUPAC name

4-fluoro-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-(2-phenylethyl)benzamide

SMILES

Cc(cc1)ccc1-c(cc1)nnc1N(CC1)CCN1C(CN(CCc1ccccc1)C(c(cc1)ccc1F)=O)=O

InChI

InChI=1S/C32H32FN5O2/c1-24-7-9-26(10-8-24)29-15-16-30(35-34-29)36-19-21-37(22-20-36)31(39)23-38(18-17-25-5-3-2-4-6-25)32(40)27-11-13-28(33)14-12-27/h2-16H,17-23H2,1H3

InChI Key

NSRDMDKBGXYSRM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19832454

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

537.64

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.759

Distribution Coefficient, logD

4.738

Water Solubility, LogSw

-4.55

Polar Surface Area

56.744

Acid Dissociation Constant (pKa)

21.99

Base Dissociation Constant (pKb)

6.09

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

V026-5549 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V026-5549 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V026-5549?
Check Price and Availability of V026-5549, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V026-5549 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V026-5549
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V026-5549
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V026-5549 available by request